838
Views
33
CrossRef citations to date
0
Altmetric
Report

Human TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: A potential therapeutic use

, , , &
Pages 80-85 | Received 26 Jul 2012, Accepted 18 Oct 2012, Published online: 05 Dec 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yanchun Gao, Ruihong Wang, Lin Liu, Shitao Feng, Xiaozhi Xi, Wengong Yu, Yuchao Gu & Ye Wang. (2023) Identification and characterization of shark VNARs targeting the Helicobacter pylori adhesin HpaA. Artificial Cells, Nanomedicine, and Biotechnology 51:1, pages 509-519.
Read now
Yongzhong Wang, Zhen Fan, Lei Shao, Xiaowei Kong, Xianjuan Hou, Dongrui Tian, Ying Sun, Yazhong Xiao & Li Yu. (2016) Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications. International Journal of Nanomedicine 11, pages 3287-3303.
Read now
Stefan Zielonka, Martin Empting, Julius Grzeschik, Doreen Könning, Caroline J Barelle & Harald Kolmar. (2015) Structural insights and biomedical potential of IgNAR scaffolds from sharks. mAbs 7:1, pages 15-25.
Read now
Marina Kovaleva, Laura Ferguson, John Steven, Andrew Porter & Caroline Barelle. (2014) Shark variable new antigen receptor biologics – a novel technology platform for therapeutic drug development. Expert Opinion on Biological Therapy 14:10, pages 1527-1539.
Read now

Articles from other publishers (29)

Karen Manoutcharian & Goar Gevorkian. (2023) Shark VNAR phage display libraries: An alternative source for therapeutic and diagnostic recombinant antibody fragments. Fish & Shellfish Immunology 138, pages 108808.
Crossref
Jianqing Wen, Jinyu Gong, Pengwei Li, Penghui Deng, Mengsi Sun, Yujie Wu, Chenxi Tian, Hao Wang & Yunchen Bi. (2023) Identification and characterization of IgNAR and VNAR repertoire from the ocellate spot skate (Okamejei kenojei). Frontiers in Marine Science 10.
Crossref
Mirna Burciaga-Flores, Ana Laura Márquez-Aguirre, Salvador Dueñas, Jahaziel Gasperin-Bulbarela, Alexei F. Licea-Navarro & Tanya A. Camacho-Villegas. (2023) First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment. Scientific Reports 13:1.
Crossref
Guillermo Valenzuela-Nieto, Zaray Miranda-Chacon, Constanza Salinas-Rebolledo, Ronald Jara, Alexei Cuevas, Anne Berking & Alejandro Rojas-Fernandez. (2022) Nanobodies: COVID-19 and Future Perspectives. Frontiers in Drug Discovery 2.
Crossref
Dan Li, Hejiao English, Jessica Hong, Tianyuzhou Liang, Glenn Merlino, Chi-Ping Day & Mitchell Ho. (2022) A novel PD-L1-targeted shark VNAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer. Molecular Therapy - Oncolytics 24, pages 849-863.
Crossref
Ana Carolina Alcala Aristiguieta. 2022. Biomedical Innovations to Combat COVID-19. Biomedical Innovations to Combat COVID-19 231 240 .
Jahaziel Gasperin-Bulbarela, Olivia Cabanillas-Bernal, Salvador Dueñas & Alexei F. Licea-Navarro. 2022. Single-Domain Antibodies. Single-Domain Antibodies 71 93 .
Samata S. Pandey, Marina Kovaleva, Caroline J. Barelle & Obinna C. Ubah. 2022. Single-Domain Antibodies. Single-Domain Antibodies 19 33 .
Likun Wei, Meiniang Wang, Haitao Xiang, Yuan Jiang, Jinhua Gong, Dan Su, M. A. R. Al Azad, Hongming Dong, Limin Feng, Jiajun Wu, Leo Lai Chan, Naibo Yang & Jiahai Shi. (2021) Bamboo Shark as a Small Animal Model for Single Domain Antibody Production. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Yasaman Asaadi, Fatemeh Fazlollahi Jouneghani, Sara Janani & Fatemeh Rahbarizadeh. (2021) A comprehensive comparison between camelid nanobodies and single chain variable fragments. Biomarker Research 9:1.
Crossref
Salma Nassor Juma, Xiaoxia Gong, Sujie Hu, Zhengbing Lv, Jianzhong Shao, Lili Liu & Guiqian Chen. (2021) Shark New Antigen Receptor (IgNAR): Structure, Characteristics and Potential Biomedical Applications. Cells 10:5, pages 1140.
Crossref
Wei Shien Cheong, Chiuan Yee Leow, Abu Bakar Abdul Majeed & Chiuan Herng Leow. (2020) Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody. International Journal of Biological Macromolecules 147, pages 369-375.
Crossref
Hejiao English, Jessica Hong & Mitchell Ho. (2020) Ancient species offers contemporary therapeutics: an update on shark VNAR single domain antibody sequences, phage libraries and potential clinical applications. Antibody Therapeutics 3:1, pages 1-9.
Crossref
Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard & Martine J. Smit. (2019) Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3. Molecular Pharmacology 96:6, pages 753-764.
Crossref
Olivia Cabanillas-Bernal, Salvador Dueñas, Marta Ayala-Avila, Alexandra Rucavado, Teresa Escalante & Alexei F. Licea-Navarro. (2019) Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3. PLOS ONE 14:6, pages e0213394.
Crossref
D.P.N. De Silva, E. Tan, N. Mizuno, S. Hosoya, Md S. Reza, S. Watabe, S. Kinoshita & S. Asakawa. (2019) Transcriptomic analysis of immunoglobulin novel antigen receptor (IgNAR) heavy chain constant domains of brownbanded bamboo shark (Chiloscyllium punctatum). Fish & Shellfish Immunology 84, pages 370-376.
Crossref
Sara Žigon-Branc, Ariana Barlič, Miomir Knežević, Matjaž Jeras & Gordana Vunjak-Novakovic. (2018) Testing the potency of anti-TNF-α and anti-IL-1β drugs using spheroid cultures of human osteoarthritic chondrocytes and donor-matched chondrogenically differentiated mesenchymal stem cells. Biotechnology Progress 34:4, pages 1045-1058.
Crossref
Tanya Camacho-Villegas, María Mata-González, Walter García-Ubbelohd, Linda Núñez-García, Carolina Elosua, Jorge Paniagua-Solis & Alexei Licea-Navarro. (2018) Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF165 Neutralization. Marine Drugs 16:4, pages 113.
Crossref
Chiuan Herng Leow, Qin Cheng, Katja Fischer & James McCarthy. 2018. Antibody Engineering. Antibody Engineering.
Obinna C. Ubah, John Steven, Marina Kovaleva, Laura Ferguson, Charlotte Barelle, Andrew J. R. Porter & Caroline J. Barelle. (2017) Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development. Frontiers in Immunology 8.
Crossref
Chiuan Leow, Katja Fischer, Chiuan Leow, Qin Cheng, Candy Chuah & James McCarthy. (2017) Single Domain Antibodies as New Biomarker Detectors. Diagnostics 7:4, pages 52.
Crossref
Doreen Könning, Laura Rhiel, Martin Empting, Julius Grzeschik, Carolin Sellmann, Christian Schröter, Stefan Zielonka, Stephan Dickgießer, Thomas Pirzer, Desislava Yanakieva, Stefan Becker & Harald Kolmar. (2017) Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders. Scientific Reports 7:1.
Crossref
Sara Mashoof & Michael Criscitiello. (2016) Fish Immunoglobulins. Biology 5:4, pages 45.
Crossref
Doreen Könning, Stefan Zielonka, Carolin Sellmann, Christian Schröter, Julius Grzeschik, Stefan Becker & Harald Kolmar. (2016) Isolation of a pH-Sensitive IgNAR Variable Domain from a Yeast-Displayed, Histidine-Doped Master Library. Marine Biotechnology 18:2, pages 161-167.
Crossref
Martin F. Flajnik. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology 160 165 .
Caroline Barelle & Andy Porter. (2015) VNARs: An Ancient and Unique Repertoire of Molecules That Deliver Small, Soluble, Stable and High Affinity Binders of Proteins. Antibodies 4:3, pages 240-258.
Crossref
Ariana Barlič, Sara Žigon, Andrej Blejec & Nevenka Kregar Velikonja. (2015) Gene expression of cultured human chondrocytes as a model for assessing neutralization efficacy of soluble TNFα by TNFα antagonists. Biologicals 43:3, pages 171-180.
Crossref
Weizao Chen, Ponraj Prabakaran & Dimiter S. Dimitrov. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 487 518 .
Jinny L. Liu, Dan Zabetakis, Jazmine C. Brown, George P. Anderson & Ellen R. Goldman. (2014) Thermal stability and refolding capability of shark derived single domain antibodies. Molecular Immunology 59:2, pages 194-199.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.